The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
Federal funding opportunity RFA-DK-27-116 from National Institutes of Health.
View forecast on Grants.gov →Forecasted — not yet open
- Posted
- September 18, 2025
- Closes
- See announcement
- Program funding
- $6,400,000
- Expected awards
- 9
- Cost sharing
- No
- Instrument
- Cooperative Agreement
- Assistance listing
- 93.847
- Category
- Health
Program funding history
Awards made under Assistance Listing 93.847 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $1.9B
- FY2025 obligated
- $2B
- FY2026 (to date) obligated
- $1B
- Awards in window
- 8,079
Top recipients: Regents of the University of Michigan, Trustees of the University of Pennsylvania, the, Washington University, the, University of Pittsburgh - of the Commonwealth System of Higher Education, Regents of the University of California, San Francisco, the
Source: USAspending.gov · refreshed July 2026
Synopsis
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC). The IBDGC has led collaborative efforts resulting in the identification of >300 genetic risk loci for different IBD subtypes across patient populations and characterization of underlying biological mechanisms. Despite advances in biological understanding and the development of a range of biologic therapies, IBD remains a chronic, severe and heterogenous disease with no cure requiring multiple interventions over the life course. Diagnostic biomarkers and accurate predictors of critical outcomes including disease remission, recurrence, and response to specific therapies are lacking. The IBDGC will leverage patient cohorts, biospecimens and advances in data science to characterize the interactions of genetic, clinical and environmental factors in disease development and progression, and to develop new predictors of disease outcomes, with the goal of improving medical management and advancing precision medicine for IBD patients. The IBDGC may include up to 7 Genomic Research Centers with varying research emphases, which will serve as sites for participant enrollment, molecular analysis of biospecimens and bioinformatics and computational analyses.
Who can apply
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Small businesses
- City or township governments
- Native American tribal governments (Federally recognized)
- State governments
- County governments
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Private institutions of higher education
- Independent school districts
- Special district governments
- For profit organizations other than small businesses
- Public housing authorities/Indian housing authorities
- Public and State controlled institutions of higher education
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.
Similar grants
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Never miss a funding deadline again
Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.
Get funding alerts